The institutional selling cluster aligns with Amrize's lowered guidance and negative free cash flow, reinforcing a cautious outlook. Monitor Q4 2026 results for any reversal in the Building Envelope segment's 14.6% EBITDA decline and whether free cash flow turns positive. Insider buying of $2.6M provides a partial offset but is insufficient to override the institutional bearish signal.
Executive Summary
Three institutional investors reduced their Amrize positions in Q3 2026, with aggregate net selling of $6.0M, led by Swedbank Ab's near-exit (-86.7% of shares). The selling follows Amrize's Q3 earnings miss on revenue and lowered full-year guidance, suggesting institutional disappointment with the company's outlook amid cost inflation and negative free cash flow.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$6.0M
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Swedbank Ab | NEAR_EXIT | -86.7% | $3.6M | -$3.3M |
| D.a. Davidson & | TRIM | -31.8% | $4.8M | -$2.5M |
| Mirae Asset Global Investments Co. | TRIM | -67.3% | $215.0K | -$166.0K |
Key Facts
- Three institutions reduced Amrize holdings in Q3 2026 with aggregate net selling of $6.0M
- Swedbank Ab executed a near-exit, reducing its position by 86.7% ($3.3M sold)
- D.A. Davidson trimmed 31.8% of its position ($2.5M sold)
- Mirae Asset Global Investments trimmed 67.3% of its position ($166K sold)
- Amrize reported Q3 2026 revenue of $3,771M (missed $3.83B consensus) and lowered full-year guidance
- Full-year 2026 revenue guidance reduced to $12.2B-$12.4B from $12.29B-$12.52B
- Adjusted EBITDA guidance cut to $2.95B-$3.05B from $3.25B-$3.34B
- Free cash flow was negative $551M year-to-date through Q3 2026
- Insider buying (11 open-market buyers including C-suite, $2.6M bought) provides a contrary signal but is outweighed by institutional selling
Financial Impact
Three institutions sold a combined $6.0M in Amrize shares during Q3 2026, with Swedbank Ab accounting for $3.3M of the total
Risk Factors
- 13F data is as of September 30, 2026; positions may have changed since quarter-end
- Institutional selling is modest in absolute terms ($6.0M) relative to $22B market cap
- Insider buying (11 buyers, $2.6M) conflicts with institutional selling direction
- Revenue and EBITDA guidance cuts suggest ongoing margin pressure from cost inflation and interest rates
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-AMRZ-2026-Q3 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 29, 2026 1d ago | Institutional Cluster | $41.61 $41.38 | ▲ +0.55% | ▼ −1.22% | No price |
Oct 28, 2026 2d ago | 8-K | $41.61 $41.38 | ▲ +0.55% | ▼ −1.22% | No price |
Sep 3, 2026 8w ago | Insider Cluster | $44.01 $43.82 | ▼ −0.43% | ▼ −0.05% | No price |
Sep 1, 2026 8w ago | 8-K | $42.97 $44.01 | ▲ +2.42% | ▲ +1.37% | No price |
Aug 31, 2026 8w ago | Insider Cluster | $43.70 $42.81 | ▼ −2.04% | ▼ −1.35% | No price |
Aug 26, 2026 9w ago | Insider Cluster | $44.29 $44.67 | ▲ +0.86% | ▲ +1.08% | No price |
Aug 26, 2026 9w ago | Insider Cluster | $44.74 $44.29 | ▼ −1.01% | ▼ −1.66% | No price |
Aug 24, 2026 9w ago | 8-K | $44.25 $44.74 | ▲ +1.11% | ▲ +1.09% | No price |
Aug 18, 2026 10w ago | Insider Cluster | $44.63 $45.26 | ▲ +1.41% | ▲ +1.20% | No price |
Aug 13, 2026 11w ago | Insider Cluster | $46.75 $46.69 | ▼ −0.13% | ▲ +0.07% | No price |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers